Nootropil is a high-purity pharmaceutical-grade nootropic agent, with the active ingredient piracetam, specifically formulated to support and enhance cognitive function. It is clinically recognized for its role in managing cortical myoclonus and as adjunctive therapy in a range of neurological conditions. This product is designed for patients under medical supervision seeking targeted neuroenhancement and cerebral metabolic support, offering a well-researched profile for specialized therapeutic applications.

Features

• Active ingredient: Piracetam 800mg or 1200mg per tablet
• Pharmaceutical-grade purity exceeding 99.5%
• Optimized bioavailability for consistent neurological uptake
• Manufactured under strict GMP (Good Manufacturing Practice) standards
• Available in blister packs of 30 or 60 tablets

Benefits

• Supports synaptic plasticity and neural communication
• Enhances learning capacity and memory consolidation under clinical conditions
• Provides adjunctive management for cortical myoclonus seizures
• Improves cognitive performance in patients with cerebral insufficiency
• Aids in recovery from hypoxic or ischemic cerebral events
• Supports mental clarity and focus in age-related cognitive decline

Common use

Nootropil is primarily indicated for the treatment of cortical myoclonus, whether used as monotherapy or in combination with other anticonvulsant agents. It is also widely utilized as an adjunctive therapy in patients experiencing cognitive decline associated with various neurological conditions, including post-stroke recovery, dementia syndromes, and dyslexic disorders in children. Off-label, it is sometimes used to support cognitive function in situations requiring heightened mental performance, though such use should be strictly medically supervised.

Dosage and direction

Dosage must be individualized based on patient condition, renal function, and therapeutic response. For cortical myoclonus, initial doses typically range from 7.2 g/day up to 24 g/day, divided into 2–3 doses. For cognitive disorders, common dosages range from 2.4 g to 4.8 g daily. Tablets should be taken whole with a sufficient amount of water, preferably with meals to minimize potential gastrointestinal discomfort. Dosage titration should be gradual and overseen by a healthcare provider. Renal function must be assessed in elderly patients or those with known kidney impairment, with dosage adjustments made accordingly.

Precautions

Patients with a history of haemorrhagic diathesis or those undergoing major surgical procedures should use Nootropil with caution due to its potential effects on platelet aggregation. Regular monitoring of renal function is advised during long-term therapy. Use in patients with hepatic impairment requires careful supervision. Discontinuation should be gradual to avoid withdrawal symptoms, especially in patients using high doses for extended periods. Not recommended for use during pregnancy or lactation unless clearly needed and under strict medical advice.

Contraindications

Nootropil is contraindicated in patients with known hypersensitivity to piracetam or any excipients in the formulation. It should not be used in patients with severe renal impairment (creatinine clearance <20 mL/min) or those with Huntington’s chorea, due to risk of exacerbating symptoms. Contraindicated in individuals with cerebral haemorrhage or acute stroke phase.

Possible side effects

Most side effects are dose-dependent and often transient. Commonly reported adverse reactions include nervousness, weight gain, drowsiness, depression, and asthenia. Gastrointestinal disturbances such as nausea, vomiting, diarrhoea, and abdominal pain may occur. Less frequently, patients may experience hyperkinesia, ataxia, confusion, or insomnia. Severe but rare side effects include angioedema, anaphylactic reactions, and thrombophlebitis. Any persistent or severe reaction should be reported immediately to a healthcare professional.

Drug interaction

Nootropil may potentiate the effects of anticoagulants and antiplatelet drugs, increasing the risk of bleeding. Concurrent use with other nootropic or psychostimulant agents may lead to overstimulation. It can interact with thyroid hormones, requiring adjustment in hormone replacement therapy. Use with caution alongside other centrally acting drugs, including antidepressants and antipsychotics, due to possible additive sedative or stimulatory effects. Always inform your physician of all concomitant medications, including over-the-counter drugs and supplements.

Missed dose

If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. Maintaining consistent blood levels is important for therapeutic efficacy, so adherence to the prescribed regimen is advised.

Overdose

Symptoms of overdose may include severe diarrhoea, abdominal pain, and pronounced lethargy. In extreme cases, haemorrhagic complications or pronounced nervous system excitation or depression may occur. There is no specific antidote; treatment is symptomatic and supportive. Gastric lavage may be considered if ingestion was recent. Haemodialysis may be effective due to piracetam’s low protein binding and high water solubility. Immediate medical attention is required in suspected overdose situations.

Storage

Store in the original packaging below 25°C, protected from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Do not dispose of medication in wastewater or household waste; return unused or expired product to a pharmacy for proper disposal.

Disclaimer

This information is intended for medical professionals and informed patients and should not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personalized recommendations and to address any health concerns or before starting any new medication. The manufacturer is not liable for misuse or incorrect interpretation of this data.

Reviews

Clinical studies and patient reports consistently highlight Nootropil’s efficacy in managing myoclonus and supporting cognitive rehabilitation. Many users note improved memory recall and mental agility within several weeks of initiation. Critical feedback occasionally references gastrointestinal side effects or the need for dose adjustment. Overall, it maintains a favourable risk-benefit profile in indicated populations when used under medical guidance.